Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (501-510 of 742) with videos related to

Pageof 75
Sort By:
JAMA Neurology|January 8, 2019
Assessment of Racial Disparities in Biomarkers for Alzheimer DiseaseJohn C Morris, Suzanne E Schindler, Lena M McCue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2018
Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imagingSuzanne E Schindler, Julia D Gray, Brian A Gordon, et al.
Plos One|February 25, 2011
Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's diseaseJohn S K Kauwe, Carlos Cruchaga, Celeste M Karch, et al.
Molecular Neurodegeneration|January 16, 2022
Murine roseolovirus does not accelerate amyloid-β pathology and human roseoloviruses are not over-represented in Alzheimer disease brainsTarin M Bigley, Monica Xiong, Muhammad Ali, et al.
Brain : a Journal of Neurology|October 20, 2021
Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer's diseaseBrendan P Lucey, Julie Wisch, Anna H Boerwinkle, et al.
Neuron|April 8, 2021
Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microgliaChao Wang, Monica Xiong, Maud Gratuze, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosisJoseph M Castellano, Rashid Deane, Andrew J Gottesdiener, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 13, 2018
Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkersSarah H Stout, Ganesh M Babulal, Chunyu Ma, et al.
The Journal of Experimental Medicine|January 16, 2024
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterationsMika P Cadiz, Katelin A Gibson, Kennedi T Todd, et al.
EMBO Molecular Medicine|October 21, 2018
High-affinity interactions and signal transduction between Aβ oligomers and TREM2Christian B Lessard, Samuel L Malnik, Yingyue Zhou, et al.
Pageof 75

Showing results (501-510 of 742) with videos related to

Sort By:
Pageof 75
JAMA Neurology|January 8, 2019
Assessment of Racial Disparities in Biomarkers for Alzheimer DiseaseJohn C Morris, Suzanne E Schindler, Lena M McCue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2018
Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imagingSuzanne E Schindler, Julia D Gray, Brian A Gordon, et al.
Plos One|February 25, 2011
Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's diseaseJohn S K Kauwe, Carlos Cruchaga, Celeste M Karch, et al.
Molecular Neurodegeneration|January 16, 2022
Murine roseolovirus does not accelerate amyloid-β pathology and human roseoloviruses are not over-represented in Alzheimer disease brainsTarin M Bigley, Monica Xiong, Muhammad Ali, et al.
Brain : a Journal of Neurology|October 20, 2021
Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer's diseaseBrendan P Lucey, Julie Wisch, Anna H Boerwinkle, et al.
Neuron|April 8, 2021
Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microgliaChao Wang, Monica Xiong, Maud Gratuze, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosisJoseph M Castellano, Rashid Deane, Andrew J Gottesdiener, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 13, 2018
Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkersSarah H Stout, Ganesh M Babulal, Chunyu Ma, et al.
The Journal of Experimental Medicine|January 16, 2024
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterationsMika P Cadiz, Katelin A Gibson, Kennedi T Todd, et al.
EMBO Molecular Medicine|October 21, 2018
High-affinity interactions and signal transduction between Aβ oligomers and TREM2Christian B Lessard, Samuel L Malnik, Yingyue Zhou, et al.
Pageof 75